Schedule 13D ownership disclosure

INTRA-CELLULAR THERAPIES INC

Security class unavailable · CUSIP: 46116X101

Event date: 2019-09-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-046544
Form type
SC 13D/A
Filer
ALAFI CAPITAL CO LLC
CIK
CIK 1216017
Filed
Sep 30, 2019
Reporting period
Sep 10, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub